“Survival Rate of Gemcitabine Monotherapy After Prior Platinum-Based Chemotherapy for Metastatic Bladder Cancer”. 2022. Cermin Dunia Kedokteran 49 (12): 693-701. https://doi.org/10.55175/cdk.v49i12.329.